b. 1942
David Botstein (born 1942) is an American geneticist and molecular biologist known primarily for his foundational contributions to genomics and human genetic mapping. He pioneered the use of restriction fragment length polymorphisms (RFLPs) as genetic markers, enabling systematic mapping of the human genome. His work has shaped the methodology of modern genetic association studies and their application to complex disease analysis.
Co-developed the use of RFLPs as genetic markers, laying groundwork for the Human Genome Project
Argued for the explanatory power of genetic association studies in understanding disease etiology
Co-founded Genome Therapeutics and contributed to the commercialization of genomic research
Chaired genetics departments at MIT, Stanford, and Princeton, shaping the field's academic direction
Recipient of the Breakthrough Prize in Life Sciences (2003) for contributions to genomics